Travel patterns and travelers’ vulnerability are changing: an increasing number of trips, travel at both ends of the age spectrum, and tourism involving close contact with local...

In France, tuberculosis has been a reportable disease since 1964. Until now, mandatory reporting has been the sole source of information on the epidemiological situation. Two...

The composition of cannabis products (herb, resin, oil), whose active ingredient is delta-9-tetrahydrocannabinol (THC), is a subject of debate in France and across Europe. Until now, the...

The National Reference Center for Mycobacterial Resistance to Antituberculosis Drugs (CNR-RMA) works alongside other national agencies to monitor mycobacterial resistance to antibiotics....

In Western European countries, as in other countries where the incidence of tuberculosis is low, the disease is primarily a problem in large cities. London, with a population of...

The National Cancer Action Plan, established in 2003 for a five-year period, identifies tobacco control as one of the top priorities in prevention. Healthcare professionals, whether...

In 2002, France had approximately 12 million regular smokers, representing 29% of the population aged 18 to 75. With the fight against smoking having become a confirmed national priority...

The vaccination schedule outlines the vaccinations required for people residing in France based on their age and summarizes the "general" vaccination recommendations issued by the CSHPF...

Breast cancer is the most common form of cancer in Western countries. In France, regional and national incidence estimates have been calculated using data from cancer registries that...